Alder has developed two unique antibody technologies that together increase antibody potency, drastically accelerate production cycles, and lower overall production costs. These unique technologies—the Antibody Selection (ABS) System and our novel Mab Xpress Antibody Production System—are cornerstones of this company and catalysts for bringing new therapeutics to market.
